MEDOPSIS
DEAD

Serial Number

97403956

Owner

Medopsis Medical Technologies Inc.

Attorney

Erin Morgan Klug

Filing Date

May 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MEDOPSIS Trademark

Serial Number: 97403956

MEDOPSIS is a trademark filed by Medopsis Medical Technologies Inc. on May 10, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Medopsis Medical Technologies Inc.

29 East Wilmot Street
Richmond Hill, Ontario L4B1A3 , CA

Entity Type: 03

Trademark Details

Filing Date

May 10, 2022

Registration Date

Not Registered

Goods & Services

Pharmaceutical research and development

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 1, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 1, 2025 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 24, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 24, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 24, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 24, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 18, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 18, 2024 GNSL
SUSPENSION LETTER WRITTEN
Apr 18, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 23, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 28, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 28, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 28, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 27, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 27, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jun 27, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 30, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 30, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2023 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 28, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 28, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 28, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2022 NWOS
NEW APPLICATION ENTERED
May 13, 2022 NWAP